Cervical carcinoma in the aged

Siegler, Edward E.

doi:10.1016/0002-9378(69)90512-2

Cited by 20 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…13,21,22 Finding squamous atypia in postmenopausal cervicovaginal smears, however, is infrequently associated with biopsy-proven intraepithelial lesions or HPV. 23 Thus, in the majority of cases the cytologic interpretation is considered imprecise and inaccurate.…”

Section: Discussionmentioning

confidence: 99%

Glandular and Squamous Atypia and Intraepithelial Lesions in Atrophic Cervicovaginal Smears

Ács

Gupta²,

Baloch³

2000

Acta Cytologica

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Glandular and Squamous Atypia and Intraepithelial Lesions in Atrophic Cervicovaginal Smears

Ács

Gupta²,

Baloch³

2000

Acta Cytologica

View full text Add to dashboard Cite

Gynecological Care of Elderly Women

Mandelblatt¹

1986

JAMA

View full text Add to dashboard Cite

Mortality from cervical cancer is decreasing in countries where aggressive Papanicolaou smear screening programs are in place. However, elderly women are likely to be lifelong nonusers or underusers of Papanicolaou screening, and mortality has not declined for older women. Many studies have noted that nonparticipants in Papanicolaou screening have a 2.7 to four times greater incidence of cervical cancer when they are screened compared with women who have been screened at least once. Gynecological screening was offered to 1542 elderly women in a primary care setting; 75% of the women had not had regular prior screening and 25% had never been screened. Half of these women chose to participate in our screening program. An overall prevalence rate of 13.5 per 1000 abnormal Papanicolaou smears (95% confidence interval, 5.6 to 21.4) was noted in the group. Age, race, prior screening history, and abnormal gynecological symptoms failed to predict the women who would have abnormal Papanicolaou smears. Our results suggest that cervical cancer screening should continue beyond 65 years of age if women have not received regular prior screening.

show abstract

The Cost-effectiveness of Cervical Cancer Screening for Low-Income Elderly Women

Mandelblatt

Fahs²

1988

JAMA

View full text Add to dashboard Cite

Controversy surrounds prevention policy for the elderly. While some cost-effectiveness analyses have been done for the general elderly population, to our knowledge no study has examined the provision of preventive services to a low-income elderly population. We conducted a study of the cost-effectiveness of a cervical cancer screening program for infrequently screened elderly women attending an urban municipal hospital clinic. The results of Papanicolaou testing were abnormal (malignant or premalignant) in 11 of 816 women screened. This early detection of cervical neoplasia saved +5907 and 3.7 years of life per 100 Papanicolaou tests. When average medical costs per year of life extended by screening were included, the program cost +2874 per year of life saved. Comprehensive sensitivity analyses performed on competing medical and economic points of view did not change the conclusion of a favorable cost-effectiveness ratio for screening. Our findings indicate that the benefits from some prevention programs for the elderly can offset the costs of these programs. More research is needed to guide public policy on prevention for selected population groups.

show abstract

Cervical carcinoma in the aged

Cited by 20 publications

References 3 publications

Glandular and Squamous Atypia and Intraepithelial Lesions in Atrophic Cervicovaginal Smears

Glandular and Squamous Atypia and Intraepithelial Lesions in Atrophic Cervicovaginal Smears

Gynecological Care of Elderly Women

The Cost-effectiveness of Cervical Cancer Screening for Low-Income Elderly Women

Contact Info

Product

Resources

About